Search

A protein in blood vessels that plays a role in cancer metastasis is a promising target for delivering cancer drugs to tumors using nanoparticles.

… Thursday, July 7, 2016 Summary A major challenge in cancer treatment is making sure therapies destroy cancer cells without harming normal tissues. MSK researchers who are developing new types of nanotechnology to deliver cancer drugs have found a promising target — a protein called P-selectin that can

Learn how radiation oncologists at Memorial Sloan Kettering are making radiation therapy for metastatic cancer more effective, with fewer side effects, including a new advance called ECHO.

… Thursday, July 1, 2021 With potent, knifelike beams that can sear cancer cells yet spare healthy tissue, there’s a growing arsenal of weapons pioneered by Memorial Sloan Kettering’s radiation oncologists to reach tumors that have recurred deep inside delicate regions of the body. Radiation oncologist

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Thursday, October 15, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Memorial Sloan Kettering Cancer Center Receives Press Ganey 2020 Pinnacle of Excellence Award Memorial Sloan Kettering Cancer Center MSK was awarded Press Ganey’s 2020 Pinnacle of

A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs.

… Tuesday, August 19, 2014 Summary A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs. Most cancer deaths occur when the disease spreads, or metastasizes, from the original tumor site to a distant location. In breast cancer patients

Physician-scientist Siddhartha Mukherjee, author of The Emperor of All Maladies: A Biography of Cancer, spoke to 2013 graduates of the “tenderness and tension” inherent in scientific discovery.

… Friday, May 17, 2013 Summary Physician-scientist Siddhartha Mukherjee, author of The Emperor of All Maladies: A Biography of Cancer , spoke to 2013 graduates of the “tenderness and tension” inherent in scientific discovery. “Newspapers may bring us news of a scientific-industrial complex that is increasingly

Androgen-deprivation therapy, a mainstay of prostate cancer treatment, may give prostate cells new growth abilities, scientists at Memorial Sloan Kettering have found.

… Thursday, April 30, 2020 Summary The prostate gland has a remarkable ability to regrow itself after hormone-deprivation therapy. A new study from researchers at Memorial Sloan Kettering explains why. The standard treatment for men with advanced prostate cancer is androgen-deprivation therapy. Androgens

A new imaging technology developed at MSK allows researchers to focus on genes as they are copied into messenger RNA.

… Friday, July 5, 2019 Summary For the first time, SKI investigators have found a way to peer inside living cells and observe gene transcription, the process by which DNA is copied into messenger RNA. A picture is worth a thousand words, or so the saying goes. But it can be quite a challenge to capture

During the opening clinical plenary of the American Association for Cancer Research (AACR) virtual annual meeting I on Monday, April 27, Memorial Sloan Kettering’s Charles Sawyers, MD served as a discussant and featured thought leader on two phase III BRAF-mutant melanoma trials, providing commentary and a broader outlook on the highlighted clinical trials.

… Tuesday, April 28, 2020 During the opening clinical plenary of the American Association for Cancer Research (AACR) virtual annual meeting I on Monday, April 27, Memorial Sloan Kettering’s Charles Sawyers, MD served as a discussant and featured thought leader on two phase III BRAF-mutant melanoma trials

Anesthesiologists and biomedical engineers at Memorial Sloan Kettering Cancer Center (MSK) have modified the protective boxes commonly employed during airway procedures in infectious patients, such as intubation, creating a two-piece setup instead of the usual single unit.

… Wednesday, April 8, 2020 Anesthesiologists and biomedical engineers at Memorial Sloan Kettering Cancer Center (MSK) have modified the protective boxes commonly employed during airway procedures in infectious patients, such as intubation, creating a two-piece setup instead of the usual single unit. This

Brittany Woods, who is completing her doctoral work in the laboratory of physician-scientist Ross Levine, has received a pilot award from the National Cancer Institute that supports outstanding PhD candidates

… Wednesday, October 19, 2016 Brittany Woods , a fifth-year Gerstner Sloan Kettering student, recently received the National Cancer Institute’s Predoctoral to Postdoctoral Fellow Transition Award . This pilot award will support outstanding PhD candidates as they complete their dissertation research and